The research project on biomarker-based diagnosis of early-stage liver cancers led by Dr. Kohji Yamada, Associate Professor of Department of Biotechnology, The Jikei University School of Medicine as a principal investigator and participated in by Perseus Proteomics Inc and Institute of Immunology, Co., Ltd., has been selected for the Practical Research for Innovative Cancer Control program by AMED.

Please refer to the following joint press release for details. （Click on the blue text to view the PDF.）

Joint Press Release
Announcement of Selection for Research as Practical Research for Innovative Cancer Control Program by Japan Agency for Medical Research and Development （AMED）